Conversely, in another prospective study it was shown that mutations in the growth hormone receptor (GHR) gene lead to reduced IGF-1 levels, which are associated with severe short stature in the subjects concerned and significantly reduced diabetes and BC risks [34]. This evidence concerns the gene IGF1 and breast cancer.